Skip to main navigation Skip to search Skip to main content

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.

Translated title of the contribution: Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
  • K. Beelen
  • , M. Opdam
  • , T.M. Severson
  • , R.H.T. Koornstra
  • , A.D. Vincent
  • , J. Wesseling
  • , J.J. Muris
  • , E.M.J.J. Berns
  • , J.B. Vermorken
  • , P.J. van Diest
  • , S.C. Linn

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPhosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
Original languageUndefined/Unknown
Pages (from-to)R6
Number of pages1
JournalBreast Cancer Research
Volume16
Issue number1
Publication statusPublished - 2014

Cite this